logo
logo

Maze Therapeutics Appoints Misbah Tahir As Chief Financial Officer

Sep 02, 2025•5 days ago

Position

Chief Financial Officer

Company

Maze Therapeutics

Misbah Tahir
San FranciscoBiotechnology

Description

Maze Therapeutics, Inc. has announced the appointment of Misbah Tahir as its Chief Financial Officer, effective immediately. Misbah brings over 20 years of experience in the biopharmaceutical industry and will help drive the company's growth strategy during a pivotal time.

Company Information

Company

Maze Therapeutics

Location

San Francisco, California, United States

About

Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. The company’s pipeline is led by two wholly owned lead programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease. Maze is based in South San Francisco.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months